| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.
|
Nat Genet
|
2009
|
14.16
|
|
2
|
Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis.
|
Clin Gastroenterol Hepatol
|
2005
|
2.44
|
|
3
|
Interferon therapy prolonged life expectancy among chronic hepatitis C patients.
|
Gastroenterology
|
2002
|
1.79
|
|
4
|
Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver.
|
JAMA
|
2004
|
1.78
|
|
5
|
Core protein of hepatitis C virus induces cardiomyopathy.
|
Circ Res
|
2004
|
1.73
|
|
6
|
Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
|
Am J Gastroenterol
|
2005
|
1.72
|
|
7
|
Alteration of gene expression in human hepatocellular carcinoma with integrated hepatitis B virus DNA.
|
Clin Cancer Res
|
2005
|
1.64
|
|
8
|
Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver.
|
Am J Gastroenterol
|
2002
|
1.42
|
|
9
|
Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis.
|
Hepatol Res
|
2006
|
1.40
|
|
10
|
Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C.
|
Hum Mol Genet
|
2011
|
1.31
|
|
11
|
Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression.
|
Hepatology
|
2006
|
1.31
|
|
12
|
Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial.
|
J Viral Hepat
|
2014
|
1.23
|
|
13
|
Etiology of liver cirrhosis in Japan: a nationwide survey.
|
J Gastroenterol
|
2009
|
1.16
|
|
14
|
Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus.
|
Hepatol Res
|
2007
|
1.13
|
|
15
|
Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma.
|
Ann Surg Oncol
|
2007
|
1.12
|
|
16
|
Detection of serum hepatitis B virus DNA by real-time quantitative polymerase chain reaction (TaqMan PCR) during lamivudine treatment: comparison with three other assays.
|
Hepatol Res
|
2003
|
1.11
|
|
17
|
ITPA gene variant protects against anemia induced by pegylated interferon-α and ribavirin therapy for Japanese patients with chronic hepatitis C.
|
Hepatol Res
|
2010
|
1.09
|
|
18
|
Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update.
|
Hepatol Res
|
2012
|
1.07
|
|
19
|
Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study.
|
J Gastroenterol
|
2014
|
0.98
|
|
20
|
p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection.
|
Intervirology
|
2004
|
0.97
|
|
21
|
Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice.
|
Hepatology
|
2013
|
0.96
|
|
22
|
Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009).
|
Hepatol Res
|
2010
|
0.95
|
|
23
|
Problems in serum albumin measurement and clinical significance of albumin microheterogeneity in cirrhotics.
|
Nutrition
|
2004
|
0.94
|
|
24
|
Serial changes in expression of functionally clustered genes in progression of liver fibrosis in hepatitis C patients.
|
World J Gastroenterol
|
2008
|
0.94
|
|
25
|
Hepatitis B virus genotypes and response to antiviral therapy.
|
Clin Lab
|
2006
|
0.94
|
|
26
|
Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: A case-control study.
|
Hepatol Res
|
2006
|
0.94
|
|
27
|
L-carnitine inhibits hepatocarcinogenesis via protection of mitochondria.
|
Int J Cancer
|
2005
|
0.93
|
|
28
|
Effect of oral supplementation with branched-chain amino acid granules on serum albumin level in the early stage of cirrhosis: a randomized pilot trial.
|
Hepatol Res
|
2003
|
0.93
|
|
29
|
Disease associations and altered immune function in CD45 138G variant carriers.
|
Hum Mol Genet
|
2004
|
0.92
|
|
30
|
Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.
|
J Med Virol
|
2007
|
0.92
|
|
31
|
A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C.
|
Gut
|
2007
|
0.91
|
|
32
|
Elevation of the glycated albumin to glycated hemoglobin ratio during the progression of hepatitis C virus related liver fibrosis.
|
World J Hepatol
|
2012
|
0.91
|
|
33
|
The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study.
|
Hepatol Res
|
2008
|
0.91
|
|
34
|
Oncostatin M gene therapy attenuates liver damage induced by dimethylnitrosamine in rats.
|
Am J Pathol
|
2007
|
0.90
|
|
35
|
Hemodynamic analysis and treatment of an enlarging extrahepatic portal aneurysm: report of a case.
|
Surg Today
|
2014
|
0.90
|
|
36
|
Combination therapy with a nucleos(t)ide analogue and interferon for chronic hepatitis B: simultaneous or sequential.
|
J Gastroenterol
|
2013
|
0.90
|
|
37
|
New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography.
|
J Gastroenterol
|
2013
|
0.89
|
|
38
|
Association of amino acid imbalance with the severity of liver fibrosis and esophageal varices.
|
Ann Hepatol
|
2013
|
0.89
|
|
39
|
HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
|
J Med Virol
|
2003
|
0.89
|
|
40
|
Ureterocolic fistula detected on bone scintigraphy.
|
Indian J Gastroenterol
|
2004
|
0.88
|
|
41
|
Distinct geographic distributions of hepatitis B virus genotypes in patients with acute infection in Japan.
|
J Med Virol
|
2005
|
0.88
|
|
42
|
Chemiluminescence enzyme immunoassay for monitoring hepatitis C virus core protein during interferon-alpha2b and ribavirin therapy in patients with genotype 1 and high viral loads.
|
J Med Virol
|
2005
|
0.88
|
|
43
|
Comparison between mucinous cystic neoplasm and intraductal papillary mucinous neoplasm of the branch duct type of the pancreas with respect to expression of CD10 and cytokeratin 20.
|
Pancreas
|
2009
|
0.88
|
|
44
|
Plummer-Vinson syndrome successfully treated by endoscopic dilatation.
|
J Gastroenterol Hepatol
|
2007
|
0.88
|
|
45
|
Nutritional status and quality of life in current patients with liver cirrhosis as assessed in 2007-2011.
|
Hepatol Res
|
2013
|
0.87
|
|
46
|
Involvement of hepatoma-derived growth factor in the growth inhibition of hepatocellular carcinoma cells by vitamin K(2).
|
J Gastroenterol
|
2009
|
0.87
|
|
47
|
Clinical characteristics of patients who developed hepatocellular carcinoma after hepatitis C virus eradication with interferon therapy: current status in Japan.
|
Intern Med
|
2013
|
0.86
|
|
48
|
Crucial role of impaired Kupffer cell phagocytosis on the decreased Sonazoid-enhanced echogenicity in a liver of a nonalchoholic steatohepatitis rat model.
|
Hepatol Res
|
2010
|
0.86
|
|
49
|
Nationwide survey in Japan regarding splenectomy/partial splenic embolization for interferon treatment targeting hepatitis C virus-related chronic liver disease in patients with low platelet count.
|
Hepatol Res
|
2013
|
0.85
|
|
50
|
Differences of hepatocellular carcinoma patients with hepatitis B virus genotypes of Ba, Bj or C in Japan.
|
Intervirology
|
2005
|
0.85
|
|
51
|
Primary squamous cell carcinoma of the liver: an uncommon finding in contrast-enhanced ultrasonography imaging.
|
Case Rep Gastroenterol
|
2011
|
0.85
|
|
52
|
Anticarcinogenic impact of interferon therapy on the progression of hepatocellular carcinoma in patients with chronic viral infection.
|
Hepatol Res
|
2011
|
0.85
|
|
53
|
Factors Associated With Protein-energy Malnutrition in Chronic Liver Disease: Analysis Using Indirect Calorimetry.
|
Medicine (Baltimore)
|
2016
|
0.85
|
|
54
|
Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment of chronic hepatitis B virus carriers.
|
J Med Virol
|
2005
|
0.84
|
|
55
|
Multicentric occurrence of hepatocellular carcinoma in patients with a somatic mutation of mitochondorial DNA and hepatitis C virus.
|
Hepatol Res
|
2003
|
0.84
|
|
56
|
Involvement of intracellular glutathione in zinc deficiency-induced activation of hepatic stellate cells.
|
Chem Biol Interact
|
2003
|
0.84
|
|
57
|
Sequencing of human-viral DNA junctions in hepatocellular carcinoma from patients with HCV and occult HBV infection.
|
J Med Virol
|
2003
|
0.84
|
|
58
|
Expression of connective tissue growth factor in the human liver with idiopathic portal hypertension.
|
Mol Med
|
2007
|
0.84
|
|
59
|
Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B.
|
Hepatol Res
|
2011
|
0.84
|
|
60
|
Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma.
|
J Gastroenterol
|
2004
|
0.83
|
|
61
|
Hepatoma-derived growth factor is induced in liver regeneration.
|
Hepatol Res
|
2009
|
0.83
|
|
62
|
Role of reactive oxygen species in zinc deficiency-induced hepatic stellate cell activation.
|
Free Radic Biol Med
|
2005
|
0.83
|
|
63
|
Relationship between response to previous interferon therapy and postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma.
|
Hepatol Res
|
2002
|
0.82
|
|
64
|
Clinical significance of pretreatment serum interferon-gamma-inducible protein 10 concentrations in chronic hepatitis C patients treated with telaprevir-based triple therapy.
|
Hepatol Res
|
2014
|
0.82
|
|
65
|
LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients.
|
Hepatology
|
2012
|
0.82
|
|
66
|
Portal vein thrombosis following percutaneous ethanol injection therapy for hepatocellular carcinoma.
|
Indian J Gastroenterol
|
2002
|
0.82
|
|
67
|
Two randomized controlled studies comparing the nutritional benefits of branched-chain amino acid (BCAA) granules and a BCAA-enriched nutrient mixture for patients with esophageal varices after endoscopic treatment.
|
J Gastroenterol
|
2014
|
0.81
|
|
68
|
Usefulness of viral concentration measurement by transcription-mediated amplification and hybridization protection as a prognostic factor for recurrence after resection of hepatitis B virus-related hepatocellular carcinoma.
|
Hepatol Res
|
2003
|
0.81
|
|
69
|
Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma.
|
J Surg Oncol
|
2008
|
0.81
|
|
70
|
Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan.
|
Hepatol Res
|
2006
|
0.81
|
|
71
|
Relationship between elevation of glycated albumin to glycated hemoglobin ratio in patients with a high bleeding risk of esophageal varices.
|
Hepatogastroenterology
|
2012
|
0.81
|
|
72
|
Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placebo-controlled trial.
|
J Gastroenterol
|
2014
|
0.80
|
|
73
|
Development of a new in situ hybridization method for the detection of global bacterial DNA to provide early evidence of a bacterial infection in spontaneous bacterial peritonitis.
|
J Hepatol
|
2011
|
0.80
|
|
74
|
Entecavir and interferon-α sequential therapy in Japanese patients with hepatitis B e antigen-positive chronic hepatitis B.
|
J Gastroenterol
|
2012
|
0.80
|
|
75
|
A new epitope of CYP2D6 recognized by liver kidney microsomal autoantibody from japanese patients with autoimmune hepatitis.
|
Biol Pharm Bull
|
2005
|
0.80
|
|
76
|
Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C.
|
J Gastroenterol
|
2013
|
0.80
|
|
77
|
Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B.
|
World J Surg
|
2002
|
0.80
|
|
78
|
Thiopurine S-methyltransferase gene polymorphism in Japanese patients with autoimmune liver diseases.
|
Liver Int
|
2007
|
0.80
|
|
79
|
LKM-1 sera from autoimmune hepatitis patients that recognize ERp57, carboxylesterase 1 and CYP2D6.
|
Drug Metab Pharmacokinet
|
2010
|
0.79
|
|
80
|
Gastric emptying in patients with chronic liver diseases.
|
Ann Nucl Med
|
2002
|
0.79
|
|
81
|
Lamivudine therapy for hepatitis B virus reactivation in a patient receiving intra-arterial chemotherapy for advanced hepatocellular carcinoma.
|
Hepatol Res
|
2003
|
0.79
|
|
82
|
Vitamin K2 inhibits the proliferation of HepG2 cells by up-regulating the transcription of p21 gene.
|
Hepatol Res
|
2007
|
0.79
|
|
83
|
Lack of mitochondrial DNA enhances growth of hepatocellular carcinoma in vitro and in vivo.
|
Hepatol Res
|
2006
|
0.79
|
|
84
|
Prevalence of hepatitis C virus infection among patients with hypertrophic cardiomyopathy.
|
Heart Vessels
|
2003
|
0.79
|
|
85
|
Cyclical etidronate for treatment of osteopenia in patients with cirrhosis of the liver.
|
Hepatol Res
|
2002
|
0.79
|
|
86
|
Influence of interferon therapy on outcome after surgery for hepatitis C virus-related hepatocellular carcinoma.
|
Hepatol Res
|
2006
|
0.79
|
|
87
|
Alcohol abuse as an etiologic factor for hepatocellular carcinoma in Japan.
|
Hepatol Res
|
2005
|
0.78
|
|
88
|
Long-term interferon therapy after radiofrequency ablation is effective in treating patients with HCV-associated hepatocellular carcinoma.
|
Hepatol Int
|
2010
|
0.78
|
|
89
|
Investigation of interferon-α response by a single amino acid substitution of nonstructural protein 5A in hepatitis C virus-infected patients.
|
J Interferon Cytokine Res
|
2011
|
0.78
|
|
90
|
Comparison of the effect of BCAA granules on between decompensated and compensated cirrhosis.
|
Hepatogastroenterology
|
2010
|
0.78
|
|
91
|
Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B.
|
Surg Today
|
2005
|
0.78
|
|
92
|
Differences in molecular alterations of hepatocellular carcinoma between patients with a sustained virological response and those with hepatitis C virus infection.
|
Liver Int
|
2008
|
0.78
|
|
93
|
Natural history of major complications in hepatitis C virus-related cirrhosis evaluated by per-rectal portal scintigraphy.
|
World J Gastroenterol
|
2005
|
0.78
|
|
94
|
Chemoprevention of spontaneous development of hepatocellular carcinomas in fatty liver Shionogi mice by a cyclooxygenase-2 inhibitor.
|
Cancer Sci
|
2006
|
0.78
|
|
95
|
Survey of non-B, non-C liver cirrhosis in Japan.
|
Hepatol Res
|
2013
|
0.78
|
|
96
|
Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma.
|
Oncol Rep
|
2013
|
0.78
|
|
97
|
Effects of exercise and grape juice ingestion in combination on plasma concentrations of purine bases and uridine.
|
Clin Chim Acta
|
2007
|
0.77
|
|
98
|
Mode of HCV infection examined by polymorphism of hypervariable region-1 in cases of acute hepatitis C after accidental exposure to blood-borne pathogens.
|
J Med Virol
|
2005
|
0.77
|
|
99
|
Elevation of the AST to ALT ratio in association with the severity of esophageal varices in patients with HCV-related compensated liver cirrhosis.
|
Hepatogastroenterology
|
2013
|
0.77
|
|
100
|
Lamivudine and IFN-beta sequential therapy in HBe antigen-positive patients with chronic hepatitis B virus genotype C infection.
|
J Interferon Cytokine Res
|
2007
|
0.77
|
|
101
|
Serum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C.
|
Medicine (Baltimore)
|
2016
|
0.77
|
|
102
|
Guidelines on nutritional management in Japanese patients with liver cirrhosis from the perspective of preventing hepatocellular carcinoma.
|
Hepatol Res
|
2012
|
0.77
|
|
103
|
Relationship Between Hepatic Steatosis and the Elevation of Aminotransferases in HBV-Infected Patients With HBe-Antigen Negativity and a Low Viral Load.
|
Medicine (Baltimore)
|
2016
|
0.77
|
|
104
|
Does alcohol increase the risk of hepatocellular carcinoma among patients with hepatitis C virus infection?
|
Hepatol Res
|
2006
|
0.77
|
|
105
|
Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts.
|
Hepatol Res
|
2008
|
0.77
|
|
106
|
Hepatitis C virus relapse was suppressed by long-term self-injection of low-dose interferon in patients with chronic hepatitis C after pegylated interferon plus ribavirin treatment.
|
Hepatol Res
|
2013
|
0.76
|
|
107
|
A randomized trial of 24 versus 48 weeks of peginterferon α-2a in patients infected with chronic hepatitis C virus genotype 2 or low viral load genotype 1: a multicenter national study in Japan.
|
Hepatol Int
|
2009
|
0.76
|
|
108
|
Mechanisms of the protective effect of L-alanine to D-galactosamine-induced hepatocellular injury: comparative studies of L-alanine and pyruvate.
|
Biochem Biophys Res Commun
|
2002
|
0.76
|
|
109
|
Potential role of vitamin K(2) as a chemopreventive agent against hepatocellular carcinoma.
|
Hepatol Res
|
2007
|
0.76
|
|
110
|
Partial blockage of hepatocyte maturation in hepatoma-derived growth factor transgenic mice.
|
World J Hepatol
|
2009
|
0.76
|
|
111
|
Cost-effectiveness analysis on the surveillance for hepatocellular carcinoma in liver cirrhosis patients using contrast-enhanced ultrasonography.
|
Hepatol Res
|
2012
|
0.76
|
|
112
|
Dynamics of hepatitis C virus monitored by real-time quantitative polymerase chain reaction during first 2 weeks of IFN-beta treatment are predictive of long-term therapeutic response.
|
J Interferon Cytokine Res
|
2002
|
0.76
|
|
113
|
Does a late evening meal reduce the risk of hepatocellular carcinoma among patients with chronic hepatitis C?
|
Hepatol Res
|
2008
|
0.75
|
|
114
|
B-Cell Activating Factor Belonging to the Tumor Necrosis Factor Family and Interferon-γ-Inducible Protein-10 in Autoimmune Hepatitis.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
115
|
A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
116
|
Natural course of changes in hepatic functional reserve in patients with chronic liver diseases evaluated by scintigraphy with GSA.
|
Hepatol Res
|
2003
|
0.75
|
|
117
|
A proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
118
|
Effect of psoas muscle mass after endoscopic therapy for patients with esophageal varices.
|
Medicine (Baltimore)
|
2017
|
0.75
|
|
119
|
Prognostic significance of nonprotein respiratory quotient in patients with liver cirrhosis.
|
Medicine (Baltimore)
|
2017
|
0.75
|
|
120
|
SEN viruses and treatment response in chronic hepatitis C virus.
|
Lancet
|
2002
|
0.75
|
|
121
|
Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C.
|
Hum Genet
|
2014
|
0.75
|
|
122
|
Changes in skeletal muscle mass after endoscopic treatment in patients with esophageal varices.
|
Medicine (Baltimore)
|
2017
|
0.75
|
|
123
|
Time Course of Change in Glutathione S-Transferase Positive Foci and Ornithine Decarboxylase Activity after Cessation of Long-term Alcohol Administration in Rats.
|
Asian Pac J Cancer Prev
|
2001
|
0.75
|
|
124
|
[Sequential therapy with a nucleos(t)ide analogue and interferon in patients with chronic hepatitis B: efficacy and limitations].
|
Nihon Shokakibyo Gakkai Zasshi
|
2011
|
0.75
|
|
125
|
Timing of interferon therapy and sources of infection in patients with acute hepatitis C.
|
Hepatol Res
|
2005
|
0.75
|
|
126
|
Adefovir dipivoxil to prevent exacerbation of lamivudine-resistant hepatitis B infection during chemotherapy for non-Hodgkin's lymphoma.
|
Am J Gastroenterol
|
2004
|
0.75
|
|
127
|
An autopsy case of POEMS syndrome with a high level of IL-6 and VEGF in the serum and ascitic fluid.
|
Intern Med
|
2002
|
0.75
|
|
128
|
Regional hepatic regeneration after liver resection correlates well with preceding changes in the regional portal circulation in humans.
|
Dig Dis Sci
|
2013
|
0.75
|
|
129
|
Two cases of intrahepatic cholangiocarcinoma detected after interferon therapy for chronic hepatitis C.
|
Hepatogastroenterology
|
2005
|
0.75
|
|
130
|
Gastric ulcer detected incidentally by renal scintigraphy.
|
Indian J Gastroenterol
|
2004
|
0.75
|
|
131
|
Sarcopenia and Sarcopenic Obesity Are Prognostic Factors for Overall Survival in Patients with Cirrhosis.
|
Intern Med
|
2016
|
0.75
|
|
132
|
Does colitis associated with primary sclerosing cholangitis represent an actual subset of ulcerative colitis?
|
Hepatogastroenterology
|
2003
|
0.75
|
|
133
|
[Present status of community-based HCV screening in Osaka City and evaluation of the utility of follow-up programs on hepatitis].
|
Nihon Koshu Eisei Zasshi
|
2008
|
0.75
|
|
134
|
[PEG-IFN/IFN monotherapy].
|
Nihon Rinsho
|
2015
|
0.75
|
|
135
|
Changes in serum levels of hepatitis C virus genotype 1b monitored by real-time quantitative polymerase chain reaction as a predictor of long term response to interferon-alpha treatment.
|
Am J Gastroenterol
|
2002
|
0.75
|
|
136
|
Polyamine metabolism and recurrence after resection for hepatocellular carcinoma.
|
Hepatogastroenterology
|
2004
|
0.75
|
|
137
|
Hepatocellular carcinoma fed by an aberrant posterior right hepatic artery.
|
Hepatogastroenterology
|
2003
|
0.75
|
|
138
|
A new era of the HCV treatment with oral agents.
|
Nihon Shokakibyo Gakkai Zasshi
|
2016
|
0.75
|
|
139
|
Vitamin K2 downregulates the expression of fibroblast growth factor receptor 3 in human hepatocellular carcinoma cells.
|
Hepatol Res
|
2009
|
0.75
|
|
140
|
[Non-invasive assessment of liver fibrosis: Ultrasound elastography and MR elastography].
|
Nihon Rinsho
|
2015
|
0.75
|
|
141
|
Ultrasonographic diagnosis of degree of chronic type C liver disease.
|
Hepatogastroenterology
|
2005
|
0.75
|
|
142
|
[A case of hepatocellular carcinoma with autoimmune hepatitis showing marked reduction of tumors by oral administration of UFT-E].
|
Gan To Kagaku Ryoho
|
2010
|
0.75
|
|
143
|
Optimal duration of additional therapy after biochemical and virological responses to lamivudine in patients with HBeAg-negative chronic hepatitis B: a randomized trial.
|
Hepatol Res
|
2008
|
0.75
|
|
144
|
[Diagnosis of liver fibrosis in patients with chronic hepatitis using serum enhanced liver fibrosis (ELF)].
|
Nihon Rinsho
|
2015
|
0.75
|
|
145
|
[Epidemiology of hepatitis C virus and hepatocellular carcinoma in Japan].
|
Nihon Rinsho
|
2004
|
0.75
|
|
146
|
Retreatment with peginterferon α-2a + ribavirin in patients who failed previous peginterferon α-2b + ribavirin combination therapy.
|
Dig Dis
|
2012
|
0.75
|
|
147
|
[Prevalence and clinical course in HBV and HCV dual chronic infection].
|
Nihon Rinsho
|
2004
|
0.75
|
|
148
|
[Mechanism and clinical application of carcinogenesis control by IFN].
|
Nihon Rinsho
|
2006
|
0.75
|
|
149
|
Effects of marker for hepatic fibrosis and viral status on recurrence after resection of hepatitis B virus-related hepatocellular carcinoma.
|
Hepatogastroenterology
|
2003
|
0.75
|
|
150
|
Cessation of Long-term Alcohol Administration and Two-day Cycling of Exposure Respectively Promote and Inhibit Hepatocarcinogenesis in Rats.
|
Asian Pac J Cancer Prev
|
2000
|
0.75
|
|
151
|
Successful pediatric living donor liver transplantation from carrier to carrier of hereditary butyrylcholinesterase variant.
|
Pediatr Transplant
|
2007
|
0.75
|
|
152
|
[Splenectomy before antiviral therapy for patients with chronic hepatitis C with thrombocytopenia].
|
Nihon Rinsho
|
2011
|
0.75
|
|
153
|
Previous or occult hepatitis B virus infection in hepatitis B surface antigen-negative and anti-hepatitis C-negative patients with hepatocellular carcinoma.
|
Surg Today
|
2004
|
0.75
|
|
154
|
Abdominal ultrasonography as a new modality for the diagnosis of gastroesophageal reflux disease.
|
J Gastroenterol Hepatol
|
2010
|
0.75
|